Literature DB >> 25587653

Obesity and cancer: local and systemic mechanisms.

Neil M Iyengar1, Clifford A Hudis, Andrew J Dannenberg.   

Abstract

Obesity is a leading modifiable risk factor for the development of several epithelial malignancies. In addition to increasing risk, obesity also confers worse prognosis for many cancers. Obesity represents an overall state of energy imbalance frequently associated with systemic effects including insulin resistance, altered hormone signaling, and high circulating levels of proinflammatory mediators. In addition to its systemic effects, obesity causes subclinical white adipose inflammation including increased tissue levels of proinflammatory mediators. Both local and systemic effects are likely to contribute to the development and progression of cancer. An understanding of the interplay between local and systemic alterations involved in the obesity-cancer link provides the basis for developing interventions aimed at mitigating the protumorigenic effects.

Entities:  

Keywords:  adipocytes; adipose tissue; body mass index; cancer risk; inflammation; insulin resistance; macrophages; metabolic syndrome

Mesh:

Substances:

Year:  2015        PMID: 25587653     DOI: 10.1146/annurev-med-050913-022228

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  104 in total

1.  Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity.

Authors:  Huda H Al-Khalaf; Mrad Amir; Falah Al-Mohanna; Asma Tulbah; Adher Al-Sayed; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

2.  Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.

Authors:  Kotha Subbaramaiah; Neil M Iyengar; Monica Morrow; Olivier Elemento; Xi Kathy Zhou; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 3.  Insights into the relationships between diabetes, prediabetes, and cancer.

Authors:  Lorenzo Scappaticcio; Maria Ida Maiorino; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

Review 4.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

5.  Fatty acid composition in mammary adipose tissue measured by Gradient-echo Spectroscopic MRI and its association with breast cancers.

Authors:  Alana A Lewin; Pippa Storey; Melanie Moccaldi; Linda Moy; S Gene Kim
Journal:  Eur J Radiol       Date:  2019-05-01       Impact factor: 3.528

6.  Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index.

Authors:  Neil M Iyengar; Kristy A Brown; Xi Kathy Zhou; Ayca Gucalp; Kotha Subbaramaiah; Dilip D Giri; Heba Zahid; Priya Bhardwaj; Nils K Wendel; Domenick J Falcone; Hanhan Wang; Samantha Williams; Michael Pollak; Monica Morrow; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-07

Review 7.  Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms.

Authors:  Gaius J Augustus; Nathan A Ellis
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

Review 8.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

9.  Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.

Authors:  Wenlian Zhu; Susan Harvey; Katarzyna J Macura; David M Euhus; Dmitri Artemov
Journal:  Clin Breast Cancer       Date:  2016-07-28       Impact factor: 3.225

Review 10.  Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Authors:  Ayca Gucalp; Neil M Iyengar; Clifford A Hudis; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.